Sun Pharmaceutical Industries

Sector: Healthcare

Followers

0
0
5
5
.
5
5
7
7
6
6
,
1
1
-17.60 (-1.04%)

As on 17 Apr, 2026 | 15:59

Open Trading A/c
Day Range
1,670.50
1,696.90
LH
52 Week Range
1,548.00
1,851.20
LH
Volume
* i
Bid / Ask
3,146,482.00
1,675.50 / 442.00

Sun Pharmaceutical Industries Announcements

Outcome of Postal Ballot dated 17 March 2026

17 Apr, 2026 | 10:47pm • Source: BSE

Rumour Verification

10 Apr, 2026 | 04:09pm • Source: BSE

The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on April 10, 2026, with reference to news appeared in https://www.moneycontrol.com dated April 10, 2026...

10 Apr, 2026 | 11:28am • Source: BSE

Intimation of newspaper advertisements about Postal Ballot/ E-Voting

08 Apr, 2026 | 03:55pm • Source: BSE

Intimation of Notice of Postal Ballot for appointment of Ms. Satyavati Berera as an Independent Director

07 Apr, 2026 | 03:50pm • Source: BSE

Submission of Confirmation Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 March 2026

06 Apr, 2026 | 04:54pm • Source: BSE

Appointment of Independent Director

04 Apr, 2026 | 03:57pm • Source: BSE

Press Release

27 Mar, 2026 | 09:11pm • Source: BSE

Intimation for Trading window closure

25 Mar, 2026 | 08:34pm • Source: BSE

Sun Pharma launches its semaglutide injection under the brand names, Noveltreat and Sematrinity in India

21 Mar, 2026 | 08:35am • Source: BSE

Newspaper publication for Notice of Postal Ballot

18 Mar, 2026 | 04:13pm • Source: BSE

Shareholder Satisfaction Survey on RTA Services

17 Mar, 2026 | 10:38am • Source: BSE

Sun Pharma announces US FDA acceptance of Supplemental Biologics License (sBLA) Application for ILUMYA

16 Mar, 2026 | 04:23pm • Source: BSE

SPIL Investor Presentation -Feb 2026

24 Feb, 2026 | 03:45pm • Source: BSE

Newspaper Advertisement for special window for transfer of Physical Shares

06 Feb, 2026 | 05:38pm • Source: BSE

Intimation of Schedule of Analyst/Institutional Investor Meeting

03 Feb, 2026 | 06:28pm • Source: BSE

Newspaper Advertisements for Unaudited Financial Results for the quarter and nine months ended 31 December 2025

01 Feb, 2026 | 01:31pm • Source: BSE

Q3FY26 Earnings Call audio recording

31 Jan, 2026 | 08:21pm • Source: BSE

Board of Directors of the Company has approved the re-appointment of Dr. Pawan Goenka as Independent director for a second term of five years effective...

31 Jan, 2026 | 05:39pm • Source: BSE

Board has approved the interim dividend for FY 2025-26

31 Jan, 2026 | 02:30pm • Source: BSE